Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03278496 · ClinicalTrials.gov registry record · NA
Recovery Housing and Drug Abuse Treatment Outcome
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 243
- Enrollment target
NCT03278496: Completed NA study, sponsored by Johns Hopkins University.
NCT03278496 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 243 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03278496, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
Study Summary
Reinforcement-Based Therapy (RBT) is an intensive outpatient substance abuse treatment that includes relapse prevention skills training, goal setting, help with finding employment and abstinence-contingent rent payment for recovery housing in the community. It is meant to provide motivation for continued abstinence while enhancing social stability. In this study, treatment was offered to inner city opiate and cocaine users immediately following a brief medically-supported residential detoxification. Previous research had shown that RBT produces 3- month outcomes superior to those for patients who are referred to outpatient treatment in the community. The present study compared outcomes for patients (N = 243) randomly assigned to receive abstinence-contingent recovery housing with (full RBT) or without additional intensive counseling or to receive usual care referral to outpatient treatment following detoxification. Outcomes were similar at 3- and 6-month follow-ups for those who received recovery housing with (full RBT) and without additional counseling and both these treatments were superior to usual care referral. Study findings support the efficacy of post-detoxification recovery housing with or without counseling for opiate and cocaine users.
Interventions
- BEHAVIORAL Recovery Housing plus Counseling
- BEHAVIORAL Usual Care Referral
- BEHAVIORAL Recovery Housing Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2001-04 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03278496
The ClinicalTrials.gov registry entry for NCT03278496 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Recovery Housing plus Counseling is the first listed.
NCT03278496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03278496 about?
NCT03278496 is a clinical study titled "Recovery Housing and Drug Abuse Treatment Outcome". Reinforcement-Based Therapy (RBT) is an intensive outpatient substance abuse treatment that includes relapse prevention skills training, goal setting, help with finding employment and abstinence-contingent rent payment for recovery housing in the community. It is meant to provide motivation for cont...
What is the current status of trial NCT03278496?
This trial is currently completed. It is a NA study. The enrollment target is 243 participants. The study started on 2001-04. Estimated completion is 2008-12.
What interventions are being tested in trial NCT03278496?
The interventions under investigation include: Recovery Housing plus Counseling (BEHAVIORAL), Usual Care Referral (BEHAVIORAL), Recovery Housing Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03278496?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.